Cases filed in Delaware
Cases 1 - 10 of 128
Takeda Pharmaceuticals U.S.A., Inc. v. Mylan Pharmaceuticals Inc. We have downloadable decisions or orders for this case
as 1:2019cv02216
Defendant: Mylan Pharmaceuticals Inc.
Plaintiff: Takeda Pharmaceuticals U.S.A., Inc.
Cause Of Action: Patent Infringement
Novartis Pharmaceuticals Corporation v. Dr. Reddys Laboratories, Inc. et al
as 1:2019cv02053
Defendant: MSN Laboratories Private Limited, Dr. Reddys Laboratories, Inc., Hetero USA Inc. and others
Plaintiff: Novartis Pharmaceuticals Corporation
Cause Of Action: Patent Infringement
Pfizer Inc. et al v. Mylan Pharmaceuticals Inc.
as 1:2019cv01863
Plaintiff: Warner-Lambert Company LLC, PF Prism C.V., Pfizer Manufacturing Holdings LLC and others
Defendant: Mylan Pharmaceuticals Inc.
Cause Of Action: Patent Infringement
In re: Palbociclib Patent Litigation
as 1:2019md02912
Not Yet Classified: Aizant Drug Research Solutions Pvt. Ltd., Hetero USA Inc., Teva Pharmaceuticals USA, Inc. and others
In Re: In re: Palbociclib Patent Litigation
Cause Of Action: Patent Infringement
City of Dover et al v. Purdue Pharma L.P. et al
as 1:2019cv01749
Defendant: Abbott Laboratories, McKesson Corporation, Purdue Pharma L.P. and others
Plaintiff: City of Seaford, City of Dover, Kent County
Cause Of Action: Diversity-Product Liability
Janssen Pharmaceuticals, Inc. et al v. Mylan Laboratories Limited et al
as 1:2019cv01488
Plaintiff: Janssen Pharmaceutica NV, Janssen Pharmaceuticals, Inc.
Defendant: Mylan Pharmaceuticals Inc., Mylan Laboratories Limited, Mylan Institutional LLC
Cause Of Action: Patent Infringement
Merck Sharp & Dohme Corp. v. Mylan Pharmaceuticals Inc. et al
as 1:2019cv01489
Defendant: Mylan Pharmaceuticals Inc.
Plaintiff: Merck Sharp & Dohme Corp.
Cause Of Action: Patent Infringement
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
as 1:2019md02902
Not Yet Classified: Merck Sharp & Dohme Corp., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc. and others
In Re: In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Cause Of Action: Patent Infringement
Keryx Biopharmaceuticals, Inc et al v. Mylan Pharmaceuticals Inc.
as 1:2019cv01445
Plaintiff: Panion & BF Biotech, Inc., Keryx Biopharmaceuticals, Inc., Chen Hsing Hsu
Defendant: Mylan Pharmaceuticals Inc.
Cause Of Action: Patent Infringement
In re: Auryxia (Ferric Citrate) Patent Litigation
as 1:2019md02896
Not Yet Classified: Chemo Research S.L., Insud Pharma S.L., Teva Pharmaceuticals USA, Inc. and others
Counter Defendant: Keryx Biopharmaceuticals, Inc., Panion & BF Biotech, Inc., Chen Hsing Hsu
Counter Claimant: Lupin Atlantis Holdings SA, Lupin Ltd.
In Re: In re: Auryxia (Ferric Citrate) Patent Litigation
Cause Of Action: Patent Infringement

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?